We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.91B
AUM Growth
+$723M
Cap. Flow
+$207M
Cap. Flow %
3.5%
Top 10 Hldgs %
67.97%
Holding
140
New
16
Increased
56
Reduced
33
Closed
12

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$271M
2
BKNG icon
Booking.com
BKNG
+$175M
3
PM icon
Philip Morris
PM
+$130M
4
V icon
Visa
V
+$66.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$41.3M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$279M
2
BBWI icon
Bath & Body Works
BBWI
+$245M
3
CVS icon
CVS Health
CVS
+$244M
4
TSM icon
TSMC
TSM
+$6.36M
5
DVA icon
DaVita
DVA
+$6.35M

Sector Composition

Rank Sector Weight
1 Financials 27.75%
2 Healthcare 19.16%
3 Consumer Discretionary 17.5%
4 Communication Services 14.74%
5 Materials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DERM
76
DELISTED
Dermira, Inc.
DERM
$2.82M 0.05%
82,746
+37,746
+84% +$1.22M
GWPH
77
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.79M 0.05%
23,026
+2,202
+11% +$270K
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.73M 0.05%
176,118
+16,118
+10% +$230K
TD icon
79
Toronto Dominion Bank
TD
$193B
$2.49M 0.04%
+37,332
New +$1.91M
CEMP
80
DELISTED
Cempra, Inc.
CEMP
$2.46M 0.04%
654,911
-237,063
-27% -$822K
SRPT icon
81
Sarepta Therapeutics
SRPT
$1.64B
$2.45M 0.04%
82,735
+79,431
+2,404% +$2.46M
ACRS icon
82
Aclaris Therapeutics
ACRS
$715M
$2.43M 0.04%
+81,500
New +$2.35M
ONCE
83
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.39M 0.04%
44,832
-10,834
-19% -$643K
BHC icon
84
Bausch Health
BHC
$1.75B
$2.36M 0.04%
214,021
– –
ATHN
85
DELISTED
Athenahealth, Inc.
ATHN
$2.24M 0.04%
19,843
+1,843
+10% +$215K
INSM icon
86
Insmed
INSM
$22.4B
$2.14M 0.04%
+122,450
New +$1.89M
HIND
87
Vyome Holdings
HIND
$14M
– –
0
– –
SPNC
88
DELISTED
Spectranetics Corp
SPNC
$1.93M 0.03%
66,206
-43,794
-40% -$1.17M
CVS icon
89
CVS Health
CVS
$135B
$1.76M 0.03%
22,470
-3,060,090
-99% -$244M
DVAX
90
DELISTED
Dynavax Technologies
DVAX
$1.69M 0.03%
284,082
+21,313
+8% +$102K
INGR icon
91
Ingredion
INGR
$6.42B
$1.65M 0.03%
13,700
– –
SIOX
92
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.64M 0.03%
+13,700
New +$1.44M
PTCT icon
93
PTC Therapeutics
PTCT
$6.18B
$1.56M 0.03%
158,686
+13,364
+9% +$162K
STOR
94
DELISTED
STORE Capital Corporation
STOR
$1.55M 0.03%
64,996
-6,004
-8% -$146K
PRTK
95
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.54M 0.03%
+80,000
New +$1.26M
SNA icon
96
Snap-on
SNA
$21.5B
$1.5M 0.03%
8,917
-4,313
-33% -$742K
RAI
97
DELISTED
Reynolds American Inc
RAI
$1.39M 0.02%
22,000
-4,639,133
-100% -$279M
CCI icon
98
Crown Castle
CCI
$34.6B
$1.35M 0.02%
14,300
– –
WBA
99
DELISTED
Walgreens Boots Alliance
WBA
$1.32M 0.02%
15,844
-5,756
-27% -$483K
TSS
100
DELISTED
Total System Services, Inc.
TSS
$1.26M 0.02%
+23,600
New +$1.26M
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q1 2017 Portfolio in Review

As of Q1 2017, C WorldWide Group held 140 positions worth $5.91B, up 14% from $5.18B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $207M of net new capital in Q1 2017, opening 16 new positions and adding to 56 existing holdings. Its largest new stake was Booking.com: 2,659,100 shares worth $189M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Reynolds American Inc, an estimated $279M trimmed.

  • C WorldWide Group's largest Q1 2017 buy was Booking.com: 2,659,100 shares worth $189M.
  • C WorldWide Group added most to Thermo Fisher Scientific in Q1 2017, an estimated $271M increase.
  • C WorldWide Group's biggest Q1 2017 reduction was Reynolds American Inc, cutting an estimated $279M.
  • C WorldWide Group fully exited Bath & Body Works in Q1 2017, selling an estimated $245M.
  • C WorldWide Group's ten largest holdings make up 68% of its $5.91B portfolio in Q1 2017.
  • C WorldWide Group opened 16 new positions and closed 12 in Q1 2017.
  • C WorldWide Group's portfolio value rose 14% quarter-over-quarter to $5.91B.

Based on C WorldWide Group's 13F filing for Q1 2017, filed 1 May 2017.